---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42681785.md"
description: "Pharmaceutical outsourcing and gene editing are two slow-burn tracks. $Asymchem(06821.HK) follows the rhythm of CDMO orders, while the potential for in vivo editing at $CRISPR Therap(CRSP.US) remains. It can't be rushed; patience is required."
datetime: "2026-07-15T10:27:03.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42681785.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42681785.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42681785.md)
author: "[每天都要喝水水](https://longbridge.com/en/profiles/17763530.md)"
---

# Pharmaceutical outsourcing and gene editing are tw…


### Related Stocks

- [06821.HK](https://longbridge.com/en/quote/06821.HK.md)
- [CRSP.US](https://longbridge.com/en/quote/CRSP.US.md)
- [002821.CN](https://longbridge.com/en/quote/002821.CN.md)